BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35912197)

  • 101. A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.
    Zhao F; Zhou Y; Ge PF; Huang CJ; Yu Y; Li J; Sun YG; Meng YC; Xu JX; Jiang T; Zhang ZX; Sun JP; Wang W
    BMC Cancer; 2017 Apr; 17(1):267. PubMed ID: 28407802
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
    D'Cunha J; Corfits AL; Herndon JE; Kern JA; Kohman LJ; Patterson GA; Kratzke RA; Maddaus MA
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):484-91; discussion 491. PubMed ID: 11882819
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
    Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
    Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Relationship between EGFR Mutations and Pathological Classification and 
Specimen of Lung Adenocarcinoma].
    Kang L; Zheng J; Zhu X
    Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):382-388. PubMed ID: 28641695
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis.
    Wang W; Hu Z; Zhao J; Huang Y; Rao S; Yang J; Xiao S; Cao R; Ye L
    J Cardiothorac Surg; 2020 Jun; 15(1):154. PubMed ID: 32600473
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A clinical spectrum of resectable lung adenocarcinoma with micropapillary component (MPC) concurrently presenting as mixed ground-glass opacity nodules.
    Zhu Z; Jiang W; Zhou D; Zhu W; Chen C
    Cancer Biomark; 2023 Nov; ():. PubMed ID: 38143336
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study.
    Dong D; Zhang S; Jiang B; Wei W; Wang C; Yang Q; Yan T; Chen M; Zheng L; Shao W; Xiong G
    Front Oncol; 2023; 13():1222716. PubMed ID: 37546402
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component.
    Li P; Liu L; Wang D; Yang R; Xuan Y; Han Y; Wang J; Guo L; Zhang L; Zhang S; Wang Y
    Front Oncol; 2022; 12():989349. PubMed ID: 36457500
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Comprehensive analysis of clinicopathological profiles in adenosquamous carcinoma of the lung.
    Wang Y; Guo H; Hou L; Wu Y; Li X; Zhao C; Cheng L; Xiong A
    Am J Transl Res; 2024; 16(1):126-135. PubMed ID: 38322563
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Development and validation of a clinical decision tool for preoperative micropapillary and solid pattern lung adenocarcinoma of CT≤2 cm.
    Gao Z; Liu S; Xiao H; Li M; Ren WG; Fen Z; Xu L; Peng ZM
    Int J Surg; 2024 Jun; ():. PubMed ID: 38896867
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Micropapillary Pattern in Invasive Mucinous Adenocarcinoma of the Lung: Comparison With Invasive Non-Mucinous Adenocarcinoma.
    He H; Li L; Wen YY; Qian LY; Yang ZQ
    Int J Surg Pathol; 2023 Nov; ():10668969231209784. PubMed ID: 37915205
    [No Abstract]   [Full Text] [Related]  

  • 113. Development of a predictive model to predict postoperative bone metastasis in pathological I-II non-small cell lung cancer.
    Zhou J; Wu D; Zheng Q; Wang T; Mei J
    Transl Lung Cancer Res; 2024 May; 13(5):998-1009. PubMed ID: 38854951
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Large nest micropapillary pattern of lung adenocarcinoma has poorer prognosis than typical floret pattern: analysis of 1,062 resected tumors.
    Kondo K; Yoshizawa A; Nakajima N; Sumiyoshi S; Teramoto Y; Rokutan-Kurata M; Sonobe M; Menju T; Date H; Haga H
    Transl Lung Cancer Res; 2020 Jun; 9(3):587-602. PubMed ID: 32676322
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Submucosal micropapillary adenocarcinoma of the sigmoid colon: A distinct and aggressive subtype of adenocarcinoma.
    Limaiem F; Hadrich Z; Omrani S; Ben Farhat L; Hajri M
    Clin Case Rep; 2023 Mar; 11(3):e7141. PubMed ID: 36968345
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Proteomic analysis reveals LRPAP1 as a key player in the micropapillary pattern metastasis of lung adenocarcinoma.
    Yan HJ; Lin SC; Xu SH; Gao YB; Zhou BJ; Zhou R; Chen FM; Li FR
    Heliyon; 2024 Jan; 10(1):e23913. PubMed ID: 38226250
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Prognostic contribution of non-predominant solid and micropapillary components in lung adenocarcinomas.
    Suzuki M; Yokose T; Nakayama H
    J Thorac Dis; 2017 Mar; 9(3):504-506. PubMed ID: 28449456
    [No Abstract]   [Full Text] [Related]  

  • 118. Micropapillary lung adenocarcinoma and micrometastasis.
    Qu Y; Aly RG; Takahashi Y; Adusumilli PS
    J Thorac Dis; 2017 Oct; 9(10):3443-3446. PubMed ID: 29268310
    [No Abstract]   [Full Text] [Related]  

  • 119. Expression of Concern: A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
    PLOS ONE Editors
    PLoS One; 2023; 18(1):e0279805. PubMed ID: 36630388
    [No Abstract]   [Full Text] [Related]  

  • 120.
    Qiao J; Zhang X; Du M; Wang P; Xin J
    Front Oncol; 2022; 12():974934. PubMed ID: 36249026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.